Q1 2021 Immunovia AB (publ) Earnings Call Transcript
Hello, and welcome to Immunovia Q1 report for 2021. (Operator Instructions)
Today, I am pleased to present Patrik Dahlen, CEO. Please begin your meeting.
()-
Thank you very much. Good afternoon, everyone. Thank you for joining us today, and thank you for your continued interest in Immunovia. My name is Patrik Dahlen. I am the CEO of Immunovia, and I will be presenting the quarter 1 2021 results for Immunovia.
Next page, Page 2. Here, you can read our disclaimers and forward-looking statements, and I encourage you to read these at your leisure.
If I could have the next page, please, Page 3. Today's agenda is as follows: I will start by discussing the importance of early detection of pancreatic cancer. Second, I will give you a summary of the Q1 highlights. Here, I will review the blind validation study and the optimization study that were presented in Q1. Thirdly, I will touch upon the road to reimbursement and reiterate how we see that process going forward. Next, I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
